Allosteric modulation of GluN2C/GluN2D-containing NMDA receptors bidirectionally modulates dopamine release: implication for Parkinson's disease.
about
Potentiation of NMDA receptor-mediated transmission in striatal cholinergic interneuronsNMDA Receptors Containing the GluN2D Subunit Control Neuronal Function in the Subthalamic Nucleus.Enhancing NMDA Receptor Function: Recent Progress on Allosteric Modulators.Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit.CIQ, a positive allosteric modulator of GluN2C/D-containing N-methyl-d-aspartate receptors, rescues striatal synaptic plasticity deficit in a mouse model of Parkinson's disease.A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal Interneurons.NMDA Receptors in the Central Nervous System.NMDA receptor blockade ameliorates abnormalities of spike firing of subthalamic nucleus neurons in a parkinsonian nonhuman primate.Striatal Tyrosine Hydroxylase Is Stimulated via TAAR1 by 3-Iodothyronamine, But Not by Tyramine or β-Phenylethylamine.
P2860
Q28649940-8878208E-790D-432B-A08B-91933E11799EQ36339205-593E4754-8FDE-4397-9903-9E7124279D1FQ39121207-38D07B79-A4F1-427F-9E6C-3FA9FA58010AQ47306135-F03B236D-A837-44FC-8B41-8CB6852D0196Q47920457-4246F367-85AA-48D0-92C6-BA9B2BA4A297Q48013669-153F012D-49EE-4CC4-85C3-4A9C4AADDF5DQ48029905-3F4C1A64-94D7-4B79-AFAE-4516D9C41839Q52632229-EAFD3C47-151D-446F-9694-B9FF6BBFD2DFQ52653144-48D86BC8-06AC-4732-8F3A-9AD74F9D9E28
P2860
Allosteric modulation of GluN2C/GluN2D-containing NMDA receptors bidirectionally modulates dopamine release: implication for Parkinson's disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Allosteric modulation of GluN2 ...... ation for Parkinson's disease.
@en
Allosteric modulation of GluN2 ...... ation for Parkinson's disease.
@nl
type
label
Allosteric modulation of GluN2 ...... ation for Parkinson's disease.
@en
Allosteric modulation of GluN2 ...... ation for Parkinson's disease.
@nl
prefLabel
Allosteric modulation of GluN2 ...... ation for Parkinson's disease.
@en
Allosteric modulation of GluN2 ...... ation for Parkinson's disease.
@nl
P2860
P356
P1476
Allosteric modulation of GluN2 ...... ation for Parkinson's disease.
@en
P2093
P2860
P304
P356
10.1111/BPH.12758
P407
P577
2014-08-01T00:00:00Z